Mira Pharmaceuticals

(NASDAQ) MIRA

Current Price$1.07

Market Cap$45.38M

Since IPO (2023)-85%

5 YearN/A

1 Year-21%

1 Month+4%

Mira Pharmaceuticals Financials at a Glance

Market Cap

$45.38M

Revenue (TTM)

$0.00

Net Income (TTM)

-$9.81M

EPS (TTM)

-$1.44

P/E Ratio

-0.75

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.07

Volume

1,004

Open

$1.07

Price

$1.07

Volume

1,004

Open

$1.07

Previous Close

$1.07

Daily Range

$1.06 - $1.07

52-Week Range

$0.90 - $2.45

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.07

Volume

1,004

Open

$1.07

Previous Close

$1.07

Daily Range

$1.06 - $1.07

52-Week Range

$0.90 - $2.45

MIRA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mira Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Erez Aminov

Website

mirapharmaceuticals.com

Headquarters

Baltimore, MD 21205, US

MIRA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-589%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-1.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$45.38M

Shares Outstanding

42.02M

Volume

1.00K

Avg. Volume

162.70K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$10.49M

EBITDA

-$10.49M

Operating Cash Flow

-$4.66M

Capital Expenditure

$0.00

Free Cash Flow

-$4.66M

Cash & ST Invst.

$6.35M

Total Debt

$0.00

Mira Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$45.38M

N/A

Market Cap/Employee

$22.69M

N/A

Employees

N/A

Net Income

-$1.15M

+35.5%

EBITDA

-$1.10M

+38.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$9.41M

+679.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.04%

N/A

Return on Invested Capital

-1.05%

N/A

Free Cash Flow

-$1.20M

+26.3%

Operating Cash Flow

-$1.20M

+26.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

POCIPrecision Optics Corporation, Inc.

POCIPrecision Optics Corporation, Inc.$5.44-0.91%

TLPHTalphera, Inc.

TLPHTalphera, Inc.$0.82-0.68%

MODDModular Medical, Inc.

MODDModular Medical, Inc.$4.98-3.11%

ANTXAN2 Therapeutics, Inc.

ANTXAN2 Therapeutics, Inc.$4.33-2.91%

QTTBQ32 Bio Inc.

QTTBQ32 Bio Inc.$11.05+7.18%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

FFord Motor Company

FFord Motor Company$17.44+0.05%

SOFISoFi Technologies

SOFISoFi Technologies$18.22+0.07%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

TAT&T

TAT&T$24.80-0.00%

Questions About MIRA

What is the current price of Mira Pharmaceuticals?

Mira Pharmaceuticals is trading at $1.07 per share.

What is the 52-week range for Mira Pharmaceuticals?

Over the past 52 weeks, Mira Pharmaceuticals has traded between $0.90 and $2.45.

How much debt does Mira Pharmaceuticals have?

As of the most recent reporting period, Mira Pharmaceuticals reported total debt of $0.00.

How much cash does Mira Pharmaceuticals have on hand?

Mira Pharmaceuticals reported $4.82M in cash and cash equivalents in its most recent financial results.

What is Mira Pharmaceuticals’s dividend yield?

Mira Pharmaceuticals does not currently have a dividend yield.

Mira Pharmaceuticals

Mira Pharmaceuticals Financials at a Glance

MIRA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Mira Pharmaceuticals

MIRA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Mira Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MIRA

What is the current price of Mira Pharmaceuticals?

What is the 52-week range for Mira Pharmaceuticals?

How much debt does Mira Pharmaceuticals have?

How much cash does Mira Pharmaceuticals have on hand?

What is Mira Pharmaceuticals’s dividend yield?

Premium Investing Services